Munich - Delayed Quote EUR

Bausch Health Companies Inc (BVF.MU)

8.01 0.00 (0.00%)
At close: April 25 at 8:11 AM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
8,757,000.00
8,757,000.00
8,124,000.00
8,434,000.00
8,027,000.00
Cost of Revenue
2,559,000.00
2,559,000.00
2,364,000.00
2,394,000.00
2,249,000.00
Gross Profit
6,198,000.00
6,198,000.00
5,760,000.00
6,040,000.00
5,778,000.00
Operating Expense
4,598,000.00
4,598,000.00
4,370,000.00
4,472,000.00
4,496,000.00
Operating Income
1,600,000.00
1,600,000.00
1,390,000.00
1,568,000.00
1,282,000.00
Net Non Operating Interest Income Expense
-1,302,000.00
-1,302,000.00
-1,450,000.00
-1,419,000.00
-1,521,000.00
Other Income Expense
-688,000.00
-688,000.00
-69,000.00
-1,173,000.00
-695,000.00
Pretax Income
-390,000.00
-390,000.00
-129,000.00
-1,024,000.00
-934,000.00
Tax Provision
221,000.00
221,000.00
83,000.00
-87,000.00
-375,000.00
Net Income Common Stockholders
-592,000.00
-592,000.00
-225,000.00
-948,000.00
-560,000.00
Diluted NI Available to Com Stockholders
-592,000.00
-592,000.00
-225,000.00
-948,000.00
-560,000.00
Basic EPS
-1.62
-1.62
-0.62
-2.64
-1.58
Diluted EPS
-1.62
-1.62
-0.62
-2.64
-1.58
Basic Average Shares
364,900.00
364,900.00
362,000.00
358,900.00
355,000.00
Diluted Average Shares
364,900.00
364,900.00
362,000.00
358,900.00
355,000.00
Total Operating Income as Reported
963,000.00
963,000.00
454,000.00
450,000.00
676,000.00
Total Expenses
7,157,000.00
7,157,000.00
6,734,000.00
6,866,000.00
6,745,000.00
Net Income from Continuing & Discontinued Operation
-592,000.00
-592,000.00
-225,000.00
-948,000.00
-560,000.00
Normalized Income
-179,800.00
-179,800.00
-174,822.80
125,340.82
-49,910.00
Interest Income
26,000.00
26,000.00
14,000.00
7,000.00
13,000.00
Interest Expense
1,328,000.00
1,328,000.00
1,464,000.00
1,426,000.00
1,534,000.00
Net Interest Income
-1,302,000.00
-1,302,000.00
-1,450,000.00
-1,419,000.00
-1,521,000.00
EBIT
938,000.00
938,000.00
1,335,000.00
402,000.00
600,000.00
EBITDA
2,202,000.00
2,202,000.00
2,729,000.00
1,954,000.00
2,425,000.00
Reconciled Cost of Revenue
2,372,000.00
2,372,000.00
2,185,000.00
2,217,000.00
2,069,000.00
Reconciled Depreciation
1,264,000.00
1,264,000.00
1,394,000.00
1,552,000.00
1,825,000.00
Net Income from Continuing Operation Net Minority Interest
-592,000.00
-592,000.00
-225,000.00
-948,000.00
-560,000.00
Total Unusual Items Excluding Goodwill
-687,000.00
-687,000.00
-68,000.00
-1,173,000.00
-694,000.00
Total Unusual Items
-687,000.00
-687,000.00
-68,000.00
-1,173,000.00
-694,000.00
Normalized EBITDA
2,889,000.00
2,889,000.00
2,797,000.00
3,127,000.00
3,119,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-274,800.00
-274,800.00
-17,822.80
-99,659.18
-183,910.00
12/31/2020 - 12/28/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade